Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis

Overview of attention for article published in European Child & Adolescent Psychiatry, February 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy: 2 policy sources
twitter: 9 X users

wikipedia: 5 Wikipedia pages

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 159 Mendeley

Summary Policy documents X Wikipedia Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder

Cited by Canadian Agency for Drugs and Technologies in Health on 26 Jul 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (‎including the 21st WHO model list of essential medicines and the 7th WHO model list of essential medicines for children)‎

Cited by World Health Organization on 30 Jan 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.